Adalimumab/InfliximabTreatment failure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2054卷 / 1期

关键词：

D O I：

10.1007/s40278-025-80607-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[31] Adalimumab/antineoplasticsAcute myeloid leukaemia (first report with adalimumab): case report
Reactions Weekly, 2009, 1233 (1) : 4 - 4
[32] Adalimumab/etanerceptUnstable diabetes mellitus (first report with adalimumab): case report
Reactions Weekly, 2007, 1134 (1) : 6 - 6
[33] Adalimumab/infliximabLupus: case report
Reactions Weekly, 2009, 1277 (1) : 6 - 6
[34] Adalimumab/etanerceptHistoplasmosis: case report
Reactions Weekly, 2015, 1569 (1) : 17 - 17
[35] Adalimumab/etanerceptDermatomyositis: case report
Reactions Weekly, 2013, 1478 (1) : 5 - 5
[36] Adalimumab/etanerceptHepatotoxicity: case report
Reactions Weekly, 2012, 1389 (1) : 7 - 7
[37] Adalimumab/infliximabOsteomyelitis: case report
Reactions Weekly, 2019, 1761 (1) : 19 - 19
[38] Adalimumab/etanerceptTuberculosis: case report
Reactions Weekly, 2020, 1800 (1) : 17 - 17
[39] Adalimumab/etanerceptDementia: case report
Reactions Weekly, 2021, 1852 (1) : 21 - 21
[40] Adalimumab/infliximabKeratopathy: case report
Reactions Weekly, 2014, 1499 (1) : 5 - 5

← 1 2 3 4 5 →